Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
This open-label, randomized trial assessed the safety of uninterrupted dabigatran versus warfarin in 635 patients undergoing ablation for atrial fibrillation. The incidence of major bleeding events was significantly lower with dabigatran than with warfarin (1.6% vs. 6.9%).
Catheter ablation of atrial fibrillation is a well-established treatment...
Alternative Titles
Full title
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1879191413
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1879191413
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1701005
